IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Apellis Pharmaceuticals, Inc

Q3 2018 vs Q4 2018

Comparing institutional holders between quarters

Quarters

Q4 2018Q3 2018Q2 2018Q1 2018Q4 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
venBio Partners L.P.
UNCHANGED
Shares1,790,102 from 1,790,102
Change0 (0%)
Value$23.6K (-$8.2K)
Filed 2019-02-14
Status
venBio Partners L.P.
UNCHANGED1,790,1021,790,10200%$31.8K$23.6K-$8.2K2019-02-14
Showing 1 of 1 institutions